Plain-English translation of NCT07571109 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called to see if it can help people with excess weight and obstructive sleep apnoea (a condition where breathing stops and starts during sleep) lose weight and improve their sleep. You would receive either the new medication or a placebo (a dummy injection with no active medicine) as a weekly injection under your skin, along with diet and exercise support.
Obstructive sleep apnoea is often linked to excess weight, and current treatments don't always fully solve the problem. This trial wants to find out if this new medication can help tackle both the weight and the sleep apnoea at the same time.
You likely qualify if…
You likely don't qualify if…
You would receive a weekly injection under your skin — either the new medication or a placebo — and follow a reduced-calorie diet and exercise plan. The study involves 300 participants total, and whether you get the real medication or placebo is decided by chance. You'll have regular visits to check how the treatment is working and monitor your sleep apnoea symptoms.
AI-generated summary from trial data · Aug 17, 2026 · Not medical advice
United States